INOGEN, INC. Operating Cash Flow
INOGEN, INC. (INGN) reported Operating Cash Flow of -$3.74 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-07
- INOGEN, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $2.95M, a 32.28% decline year-over-year.
- INOGEN, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$6.68M.
- INOGEN, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$943.00K.
- INOGEN, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $2.17M, a 69.01% decline year-over-year.
- INOGEN, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$11.22M, a 289.65% decline from fiscal 2024.
- INOGEN, INC. net cash provided by (used in) operating activities for fiscal 2024 was $5.91M.
- INOGEN, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$3.23M.
- INOGEN, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$37.53M, a 258.81% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$3.74M 10-Q · filed 2026-08-07 | -$4.68M derived: sum of 3 quarters · filed 2026-08-07 | -$2.52M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$6.68M 10-Q · filed 2026-05-08 | -$7.63M derived: sum of 2 quarters · filed 2026-05-08 | -$5.46M derived: sum of 3 quarters · filed 2026-05-08 | -$1.11M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$943.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.22M derived: sum of 2 quarters · filed 2026-02-27 | $5.57M derived: sum of 3 quarters · filed 2026-08-07 | -$11.22M 10-K · filed 2026-02-27 |
| 2025-09-30 | $2.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $6.52M derived: sum of 2 quarters · filed 2026-08-07 | -$10.27M 10-Q · filed 2025-11-06 | -$13.29M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $4.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$12.44M 10-Q · filed 2026-08-07 | -$15.46M derived: sum of 3 quarters · filed 2026-08-07 | -$8.47M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$16.79M 10-Q · filed 2026-05-08 | -$19.81M derived: sum of 2 quarters · filed 2026-05-08 | -$12.82M derived: sum of 3 quarters · filed 2026-05-08 | -$6.13M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$3.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $3.97M derived: sum of 2 quarters · filed 2026-02-27 | $10.66M derived: sum of 3 quarters · filed 2026-02-27 | $5.91M 10-K · filed 2026-02-27 |
| 2024-09-30 | $6.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $13.68M derived: sum of 2 quarters · filed 2025-11-06 | $8.93M 10-Q · filed 2025-11-06 | $5.78M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $6.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $1.94M 10-Q · filed 2025-08-08 | -$1.21M derived: sum of 3 quarters · filed 2026-02-27 | $977.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$4.75M 10-Q · filed 2025-05-08 | -$7.90M derived: sum of 2 quarters · filed 2026-02-27 | -$5.71M derived: sum of 3 quarters · filed 2026-02-27 | -$1.68M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | -$3.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$963.00K derived: sum of 2 quarters · filed 2026-02-27 | $3.07M derived: sum of 3 quarters · filed 2026-02-27 | -$3.23M 10-K · filed 2026-02-27 |
| 2023-09-30 | $2.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $6.21M derived: sum of 2 quarters · filed 2024-11-08 | -$86.00K 10-Q · filed 2024-11-08 | -$15.57M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $4.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$2.27M 10-Q · filed 2024-08-07 | -$17.75M derived: sum of 3 quarters · filed 2025-02-28 | -$27.24M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$6.30M 10-Q · filed 2024-05-08 | -$21.78M derived: sum of 2 quarters · filed 2025-02-28 | -$31.27M derived: sum of 3 quarters · filed 2025-02-28 | -$25.73M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$15.48M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$24.96M derived: sum of 2 quarters · filed 2025-02-28 | -$19.43M derived: sum of 3 quarters · filed 2025-02-28 | -$37.53M 10-K · filed 2025-02-28 |
| 2022-09-30 | -$9.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$3.95M derived: sum of 2 quarters · filed 2023-11-09 | -$22.05M 10-Q · filed 2023-11-09 | -$15.55M derived: sum of 4 quarters · filed 2024-03-01 |
| 2022-06-30 | $5.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$12.57M 10-Q · filed 2023-08-08 | -$6.07M derived: sum of 3 quarters · filed 2024-03-01 | -$9.06M derived: sum of 4 quarters · filed 2024-03-01 |
| 2022-03-31 | -$18.10M 10-Q · filed 2023-05-05 | -$11.60M derived: sum of 2 quarters · filed 2024-03-01 | -$14.59M derived: sum of 3 quarters · filed 2024-03-01 | $2.67M derived: sum of 4 quarters · filed 2024-03-01 |
| 2021-12-31 | $6.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $3.50M derived: sum of 2 quarters · filed 2024-03-01 | $20.77M derived: sum of 3 quarters · filed 2024-03-01 | $23.63M 10-K · filed 2024-03-01 |
| 2021-09-30 | -$2.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $14.28M derived: sum of 2 quarters · filed 2022-11-03 | $17.14M 10-Q · filed 2022-11-03 | $33.33M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | $17.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $20.13M 10-Q · filed 2022-08-04 | $36.33M derived: sum of 3 quarters · filed 2023-02-24 | $43.07M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | $2.86M 10-Q · filed 2022-05-05 | $19.06M derived: sum of 2 quarters · filed 2023-02-24 | $25.80M derived: sum of 3 quarters · filed 2023-02-24 | $39.33M derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | $16.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $22.94M derived: sum of 2 quarters · filed 2023-02-24 | $36.47M derived: sum of 3 quarters · filed 2023-02-24 | $37.01M 10-K · filed 2023-02-24 |
| 2020-09-30 | $6.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $20.27M derived: sum of 2 quarters · filed 2021-11-04 | $20.82M 10-Q · filed 2021-11-04 | $30.20M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $13.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $14.07M 10-Q · filed 2021-08-04 | $23.46M derived: sum of 3 quarters · filed 2022-02-24 | $38.06M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $540.00K 10-Q · filed 2021-05-04 | $9.93M derived: sum of 2 quarters · filed 2022-02-24 | $24.53M derived: sum of 3 quarters · filed 2022-02-24 | $42.96M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $9.39M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $23.99M derived: sum of 2 quarters · filed 2022-02-24 | $42.42M derived: sum of 3 quarters · filed 2022-02-24 | $40.59M 10-K · filed 2022-02-24 |
| 2019-09-30 | $14.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $33.03M derived: sum of 2 quarters · filed 2020-11-04 | $31.20M 10-Q · filed 2020-11-04 | $43.54M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $18.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $16.60M 10-Q · filed 2020-08-04 | $28.94M derived: sum of 3 quarters · filed 2021-02-24 | $43.32M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | -$1.82M 10-Q · filed 2020-05-05 | $10.51M derived: sum of 2 quarters · filed 2021-02-24 | $24.89M derived: sum of 3 quarters · filed 2021-02-24 | $45.91M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $12.34M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $26.71M derived: sum of 2 quarters · filed 2021-02-24 | $47.74M derived: sum of 3 quarters · filed 2021-02-24 | $59.98M 10-K · filed 2021-02-24 |
| 2018-09-30 | $14.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $35.40M derived: sum of 2 quarters · filed 2019-11-05 | $47.64M 10-Q · filed 2019-11-05 | $60.65M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $21.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $33.26M 10-Q · filed 2019-08-07 | $46.27M derived: sum of 3 quarters · filed 2020-02-25 | $63.65M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $12.24M 10-Q · filed 2019-05-07 | $25.25M derived: sum of 2 quarters · filed 2020-02-25 | $42.62M derived: sum of 3 quarters · filed 2020-02-25 | |
| 2017-12-31 | $13.01M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $30.38M derived: sum of 2 quarters · filed 2020-02-25 | $60.49M 10-K · filed 2020-02-25 | |
| 2017-09-30 | $17.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $47.49M 10-Q · filed 2018-11-06 | ||
| 2017-06-30 | $30.11M 10-Q · filed 2018-08-07 | |||
| 2016-12-31 | $31.03M 10-K · filed 2019-02-26 | |||
| 2014-06-30 | $9.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $8.16M 10-Q · filed 2014-08-12 | ||
| 2014-03-31 | -$1.33M 10-Q · filed 2014-05-13 | |||
| 2013-06-30 | $4.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $6.88M 10-Q · filed 2014-08-12 | ||
| 2013-03-31 | $2.69M 10-Q · filed 2014-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B |